Report Detail
Global Senolytic Drug Market Growth (Status and Outlook) 2022-2028
- RnM4472606 |
- 26 July, 2022 |
- Global |
- 86 Pages |
- LPI(LP Information) |
- Medical Industry
As the global economy mends, the 2021 growth of Senolytic Drug will have significant change from previous year. According to our (LP Information) latest study, the global Senolytic Drug market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Senolytic Drug market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Senolytic Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Senolytic Drug market, reaching US$ million by the year 2028. As for the Europe Senolytic Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Senolytic Drug players cover AgeX Therapeutics, Inc., Cleara Biotech, Eternans Ltd., and FoxBio Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Senolytic Drug market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
FOXO4-related Peptides
Bcl-2 Family Inhibitors
Navitoclax
Dasatinib and Quercetin
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
AgeX Therapeutics, Inc.
Cleara Biotech
Eternans Ltd.
FoxBio Inc
Numeric Biotech
T.A. Sciences, Inc.
Recursion Pharmaceuticals, Inc.
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Senolytic Drug Market Size 2017-2028
- 2.1.2 Senolytic Drug Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Senolytic Drug Segment by Type
- 2.2.1 FOXO4-related Peptides
- 2.2.2 Bcl-2 Family Inhibitors
- 2.2.3 Navitoclax
- 2.2.4 Dasatinib and Quercetin
- 2.2.5 Others
- 2.3 Senolytic Drug Market Size by Type
- 2.3.1 Senolytic Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Senolytic Drug Market Size Market Share by Type (2017-2022)
- 2.4 Senolytic Drug Segment by Application
- 2.4.1 Retail Pharmacies
- 2.4.2 Hospital Pharmacies
- 2.4.3 Online Pharmacies
- 2.5 Senolytic Drug Market Size by Application
- 2.5.1 Senolytic Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Senolytic Drug Market Size Market Share by Application (2017-2022)
3 Senolytic Drug Market Size by Player
- 3.1 Senolytic Drug Market Size Market Share by Players
- 3.1.1 Global Senolytic Drug Revenue by Players (2020-2022)
- 3.1.2 Global Senolytic Drug Revenue Market Share by Players (2020-2022)
- 3.2 Global Senolytic Drug Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Senolytic Drug by Regions
- 4.1 Senolytic Drug Market Size by Regions (2017-2022)
- 4.2 Americas Senolytic Drug Market Size Growth (2017-2022)
- 4.3 APAC Senolytic Drug Market Size Growth (2017-2022)
- 4.4 Europe Senolytic Drug Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Senolytic Drug Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Senolytic Drug Market Size by Country (2017-2022)
- 5.2 Americas Senolytic Drug Market Size by Type (2017-2022)
- 5.3 Americas Senolytic Drug Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Senolytic Drug Market Size by Region (2017-2022)
- 6.2 APAC Senolytic Drug Market Size by Type (2017-2022)
- 6.3 APAC Senolytic Drug Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Senolytic Drug by Country (2017-2022)
- 7.2 Europe Senolytic Drug Market Size by Type (2017-2022)
- 7.3 Europe Senolytic Drug Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Senolytic Drug by Region (2017-2022)
- 8.2 Middle East & Africa Senolytic Drug Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Senolytic Drug Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Senolytic Drug Market Forecast
- 10.1 Global Senolytic Drug Forecast by Regions (2023-2028)
- 10.1.1 Global Senolytic Drug Forecast by Regions (2023-2028)
- 10.1.2 Americas Senolytic Drug Forecast
- 10.1.3 APAC Senolytic Drug Forecast
- 10.1.4 Europe Senolytic Drug Forecast
- 10.1.5 Middle East & Africa Senolytic Drug Forecast
- 10.2 Americas Senolytic Drug Forecast by Country (2023-2028)
- 10.2.1 United States Senolytic Drug Market Forecast
- 10.2.2 Canada Senolytic Drug Market Forecast
- 10.2.3 Mexico Senolytic Drug Market Forecast
- 10.2.4 Brazil Senolytic Drug Market Forecast
- 10.3 APAC Senolytic Drug Forecast by Region (2023-2028)
- 10.3.1 China Senolytic Drug Market Forecast
- 10.3.2 Japan Senolytic Drug Market Forecast
- 10.3.3 Korea Senolytic Drug Market Forecast
- 10.3.4 Southeast Asia Senolytic Drug Market Forecast
- 10.3.5 India Senolytic Drug Market Forecast
- 10.3.6 Australia Senolytic Drug Market Forecast
- 10.4 Europe Senolytic Drug Forecast by Country (2023-2028)
- 10.4.1 Germany Senolytic Drug Market Forecast
- 10.4.2 France Senolytic Drug Market Forecast
- 10.4.3 UK Senolytic Drug Market Forecast
- 10.4.4 Italy Senolytic Drug Market Forecast
- 10.4.5 Russia Senolytic Drug Market Forecast
- 10.5 Middle East & Africa Senolytic Drug Forecast by Region (2023-2028)
- 10.5.1 Egypt Senolytic Drug Market Forecast
- 10.5.2 South Africa Senolytic Drug Market Forecast
- 10.5.3 Israel Senolytic Drug Market Forecast
- 10.5.4 Turkey Senolytic Drug Market Forecast
- 10.5.5 GCC Countries Senolytic Drug Market Forecast
- 10.6 Global Senolytic Drug Forecast by Type (2023-2028)
- 10.7 Global Senolytic Drug Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 AgeX Therapeutics, Inc.
- 11.1.1 AgeX Therapeutics, Inc. Company Information
- 11.1.2 AgeX Therapeutics, Inc. Senolytic Drug Product Offered
- 11.1.3 AgeX Therapeutics, Inc. Senolytic Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 AgeX Therapeutics, Inc. Main Business Overview
- 11.1.5 AgeX Therapeutics, Inc. Latest Developments
- 11.2 Cleara Biotech
- 11.2.1 Cleara Biotech Company Information
- 11.2.2 Cleara Biotech Senolytic Drug Product Offered
- 11.2.3 Cleara Biotech Senolytic Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 Cleara Biotech Main Business Overview
- 11.2.5 Cleara Biotech Latest Developments
- 11.3 Eternans Ltd.
- 11.3.1 Eternans Ltd. Company Information
- 11.3.2 Eternans Ltd. Senolytic Drug Product Offered
- 11.3.3 Eternans Ltd. Senolytic Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 Eternans Ltd. Main Business Overview
- 11.3.5 Eternans Ltd. Latest Developments
- 11.4 FoxBio Inc
- 11.4.1 FoxBio Inc Company Information
- 11.4.2 FoxBio Inc Senolytic Drug Product Offered
- 11.4.3 FoxBio Inc Senolytic Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 FoxBio Inc Main Business Overview
- 11.4.5 FoxBio Inc Latest Developments
- 11.5 Numeric Biotech
- 11.5.1 Numeric Biotech Company Information
- 11.5.2 Numeric Biotech Senolytic Drug Product Offered
- 11.5.3 Numeric Biotech Senolytic Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Numeric Biotech Main Business Overview
- 11.5.5 Numeric Biotech Latest Developments
- 11.6 T.A. Sciences, Inc.
- 11.6.1 T.A. Sciences, Inc. Company Information
- 11.6.2 T.A. Sciences, Inc. Senolytic Drug Product Offered
- 11.6.3 T.A. Sciences, Inc. Senolytic Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 T.A. Sciences, Inc. Main Business Overview
- 11.6.5 T.A. Sciences, Inc. Latest Developments
- 11.7 Recursion Pharmaceuticals, Inc.
- 11.7.1 Recursion Pharmaceuticals, Inc. Company Information
- 11.7.2 Recursion Pharmaceuticals, Inc. Senolytic Drug Product Offered
- 11.7.3 Recursion Pharmaceuticals, Inc. Senolytic Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 Recursion Pharmaceuticals, Inc. Main Business Overview
- 11.7.5 Recursion Pharmaceuticals, Inc. Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Senolytic Drug. Industry analysis & Market Report on Senolytic Drug is a syndicated market report, published as Global Senolytic Drug Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Senolytic Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
